Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. (ENXTPA:ALM) agreed to acquire 10% stake in Alpha MOS S.A. (ENXTPA:ALM) from Diagnostic Medical Systems S.A. (ENXTPA:DGM) for 0.9 million on November 16, 2015. Jean-Christophe Mifsud acquired 2.3 million shares of Alpha MOS S.A. for 0.4 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.726 EUR | 0.00% | +5.83% | -12.95% |
25/04 | Alpha MOS: share price advances on 'positive' outlook | CF |
25/04 | Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.95% | 2.03Cr | |
+12.85% | 23TCr | |
+13.88% | 19TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.67% | 6.41TCr | |
+18.24% | 5.21TCr | |
+7.04% | 5.19TCr | |
+10.83% | 4.43TCr | |
+5.94% | 3.68TCr |
- Stock Market
- Equities
- ALNEO Stock
- News Alpha MOS
- Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. agreed to acquire 10% stake in Alpha MOS S.A. for €0.9 million.